{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:17Z","timestamp":1784751857717,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jsat.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T02:48:56Z","timestamp":1479350936000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Carvedilol does not reduce cocaine use in methadone-maintained cocaine users"],"prefix":"10.1016","volume":"73","author":[{"given":"Mehmet","family":"Sofuoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0133-3136","authenticated-orcid":false,"given":"James","family":"Poling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Babuscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishorchandra","family":"Gonsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charla","family":"Nich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.11.005_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0306-4603(96)00038-X","article-title":"Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes","volume":"22","author":"Carroll","year":"1997","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2016.11.005_bb0010","series-title":"A cognitive-behavioral Approach: Treating cocaine addiction. NIH publication 98-4308","author":"Carroll","year":"1998"},{"issue":"8","key":"10.1016\/j.jsat.2016.11.005_bb0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: Therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2016.11.005_bb0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2009.11.010","article-title":"Cocaine and beta-blockers: The paradigm","volume":"21","author":"Damodaran","year":"2010","journal-title":"European Journal of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2016.11.005_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coph.2004.09.005","article-title":"Psychostimulants and monoamine transporters: Upsetting the balance","volume":"5","author":"Elliott","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.jsat.2016.11.005_bb0035","series-title":"Structured clinical interview for DSM-IV Axis I disorders patient edition","author":"First","year":"1996"},{"issue":"2","key":"10.1016\/j.jsat.2016.11.005_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2125.2012.04474.x","article-title":"Future pharmacological treatments for substance use disorders","volume":"77","author":"Forray","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"24","key":"10.1016\/j.jsat.2016.11.005_bb0045","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","article-title":"Carvedilol","volume":"339","author":"Frishman","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.11.005_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.jsat.2016.11.005_bb0055","series-title":"SuperMix: Mixed effects models","author":"Hedeker","year":"2008"},{"issue":"4","key":"10.1016\/j.jsat.2016.11.005_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0306-4603(98)00011-2","article-title":"Reliability and validity of the cocaine selective severity assessment [in process citation]","volume":"23","author":"Kampman","year":"1998","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/0893-164X.15.1.52","article-title":"Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment","volume":"15","author":"Kampman","year":"2001","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0376-8716(00)00193-9","article-title":"Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity","volume":"63","author":"Kampman","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.11.005_bb0075","first-page":"10","article-title":"A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms","volume":"10","author":"Kampman","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"1\u201310","key":"10.1016\/j.jsat.2016.11.005_bb0080","article-title":"Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts","volume":"11","author":"Kosten","year":"1985","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2016.11.005_bb0085","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.ijcard.2013.03.187","article-title":"Beta blocker treatment of heart failure patients with ongoing cocaine use","volume":"168","author":"Littmann","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00059-013-3976-y","article-title":"Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy","volume":"40","author":"Ocal","year":"2015","journal-title":"Herz"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2016.11.005_bb0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2010.07.022","article-title":"Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients","volume":"113","author":"Oliveto","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.11.005_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: A self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Applied Psychological Measurement"},{"key":"10.1016\/j.jsat.2016.11.005_bb0105","series-title":"Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: National findings","author":"SAMHSA","year":"2014"},{"issue":"4","key":"10.1016\/j.jsat.2016.11.005_bb0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1124\/mol.113.090118","article-title":"Adrenaline rush: The role of adrenergic receptors in stimulant-induced behaviors","volume":"85","author":"Schmidt","year":"2014","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MAJ.0b013e3182087347","article-title":"Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma","volume":"342","author":"Self","year":"2011","journal-title":"The American Journal of the Medical Sciences"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2016.11.005_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2016.11.005_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"British Journal of Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2016.11.005_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addiction Biology"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0376-8716(00)80009-5","article-title":"Carvedilol affects the physiological and behavioral response to smoked cocaine in humans","volume":"60","author":"Sofuoglu","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.jsat.2016.11.005_bb0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0269881113490326","article-title":"Functional neuroanatomy of the central noradrenergic system","volume":"27","author":"Szabadi","year":"2013","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2016.11.005_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2125.1995.tb04529.x","article-title":"The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man","volume":"40","author":"Tham","year":"1995","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"12","key":"10.1016\/j.jsat.2016.11.005_bb0150","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/13543784.2013.836488","article-title":"Pharmacotherapeutics for substance-use disorders: A focus on dopaminergic medications","volume":"22","author":"Verrico","year":"2013","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2016.11.005_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-2456(88)90048-7","article-title":"Properties of the urn randomization in clinical trials","volume":"9","author":"Wei","year":"1988","journal-title":"Controlled Clinical Trials"},{"issue":"7","key":"10.1016\/j.jsat.2016.11.005_bb0160","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216302884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216302884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:45:07Z","timestamp":1760039107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216302884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"alternative-id":["S0740547216302884"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.11.005","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carvedilol does not reduce cocaine use in methadone-maintained cocaine users","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}